Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions. Founded by Nicholas Edward Goeders in 2005, Embera NeuroTherapeutics is backed by investors that include HRA Pharma, Keiretsu Capital, Keiretsu Forum Northwest, National Institutes of Health, and Rose Research Center (RRC) in North Carolina and is headquartered in Sudbury.